Revelation Biosciences, Inc.
Revelation Biosciences, Inc. (REVB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · REVB · as of Jun 9, 2026
Key Statistics
Explore Revelation Biosciences, Inc. Data
revb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
revb competitorsREVB
ATXI
AZTR
GTBP
INDP
NKGNStock Performance
Full HistoryAbout Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting th…
what is revelation biosciences, inc. · revb stock overview · revelation biosciences, inc. company profile · who is revelation biosciences, inc. ceo · revb NASDAQ · revelation biosciences, inc. headquarters · revelation biosciences, inc. business segments
About Stock Overview & Key Data
Revelation Biosciences, Inc. (REVB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 17, 2020. As of the latest trading session, REVB stock price is $1.01, with a market capitalization of $3.9M. The stock has returned -90.29% over the past 12 months and -68.44% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Revelation Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Revelation Biosciences, Inc. reported revenue of — and net income of -$8.9M. For detailed data — including Revelation Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Revelation Biosciences, Inc. (REVB) stock price is $1.01. The stock is traded on NASDAQ under the ticker symbol REVB. The 52-week range is $0.88 – $12.88.